Company Overview

Company name: Vodis Pharmaceuticals (CNQ: VP)
Also known as: Vodis
Description: Provider of cannabis products. The company’s services include production of medical and recreational marijuana products, enabling the customers to get the products at an affordable price.
Year founded: 2011
Parent company:
Industry: Healthcare | Group: Other Healthcare | Code:
City: Delta
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 3.35
Business status: Generating Revenue
Ownership: Publicly Held
Exchange: CNQ
Ticker: VP
Revenue (USD Million): 0.00
Gross profit (USD Million):
Net income (USD Million) -2.48
Enterprise value: 6.55
Earnings before interest, tax, depreciation and amortization (EBITDA): -2.06
Fiscal period: TTM 1Q2019
Financing Status: The company (CNQ: VP) received CAD 2.015 million of development capital from an undisclosed investor on December 15, 2017 through a private placement. The proceeds from the offering will be used to complete the expansion of the company’s facility in Bellingham, Washington, and the process of upgrading its Delta, BC, location, and for general working capital and corporate purposes.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: